Capricor Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 02/07/2025 | 2.97 M | $40.94 M | 69.54% | 8.97% |
VANGUARD GROUP INC | 02/11/2025 | 2.28 M | $31.42 M | 44.42% | 6.88% |
FARALLON CAPITAL MANAGEMENT LLC | 02/14/2025 | 2.25 M | $31.06 M | 100.00% | 6.80% |
STATE STREET CORP | 02/14/2025 | 2.21 M | $30.48 M | 331.06% | 6.67% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 879,468 | $12.14 M | 37.81% | 2.66% |
ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 714,000 | $9.85 M | 150.53% | 2.16% |
MORGAN STANLEY | 02/14/2025 | 631,754 | $8.72 M | 380.36% | 1.91% |
WOODLINE PARTNERS LP | 02/14/2025 | 629,934 | $8.69 M | 100.00% | 1.90% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 576,300 | $7.95 M | 0.00% | 1.74% |
NORTHERN TRUST CORP | 02/14/2025 | 384,157 | $5.30 M | 43.30% | 1.16% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 378,000 | $5.22 M | -53.50% | 1.14% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 361,100 | $4.98 M | 20.37% | 1.09% |
CITADEL ADVISORS LLC | 02/14/2025 | 322,400 | $4.45 M | 284.27% | 0.97% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 302,100 | $4.17 M | 15.48% | 0.91% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 300,000 | $4.14 M | 0.00% | 0.91% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 294,768 | $4.07 M | 276.63% | 0.89% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 281,302 | $3.88 M | 127.94% | 0.85% |
BLACK DIAMOND FINANCIAL, LLC | 02/04/2025 | 277,737 | $3.83 M | 100.00% | 0.84% |
CITADEL ADVISORS LLC | 02/14/2025 | 265,242 | $3.66 M | 100.00% | 0.80% |
02/14/2025 | 200,000 | $2.76 M | 100.00% | 0.60% | |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 170,543 | $2.35 M | 938.88% | 0.52% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 169,111 | $2.33 M | 392.75% | 0.51% |
LMR PARTNERS LLP | 02/14/2025 | 151,800 | $2.09 M | 0.00% | 0.46% |
MAVEN SECURITIES LTD | 02/14/2025 | 150,000 | $2.07 M | 100.00% | 0.45% |
KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 144,250 | $1.99 M | 100.00% | 0.44% |
RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 126,311 | $1.74 M | 100.00% | 0.38% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 123,400 | $1.70 M | 1.31% | 0.37% |
UBS GROUP AG | 02/14/2025 | 122,818 | $1.69 M | 836.26% | 0.37% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 121,623 | $1.68 M | 100.00% | 0.37% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 119,047 | $1.64 M | 223.56% | 0.36% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 115,642 | $1.60 M | 22.04% | 0.35% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 111,336 | $1.54 M | 51.54% | 0.34% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 105,400 | $1.45 M | 20.18% | 0.32% |
UBS OCONNOR LLC | 02/14/2025 | 104,798 | $1.45 M | 26.42% | 0.32% |
OPPENHEIMER & CO INC | 02/05/2025 | 104,231 | $1.44 M | 52.37% | 0.32% |
JANE STREET GROUP, LLC | 02/14/2025 | 103,734 | $1.43 M | 4.65% | 0.31% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 95,000 | $1.31 M | 100.00% | 0.29% |
CITIGROUP INC | 02/12/2025 | 93,909 | $1.30 M | 359.15% | 0.28% |
BARCLAYS PLC | 02/13/2025 | 89,650 | $1.24 M | 147.00% | 0.27% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 87,700 | $1.21 M | 0.00% | 0.27% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 84,027 | $1.16 M | 32.56% | 0.25% |
WOLVERINE TRADING, LLC | 02/14/2025 | 78,100 | $1.07 M | 100.00% | 0.24% |
SWISS NATIONAL BANK | 02/10/2025 | 67,400 | $930,120 | 100.00% | 0.20% |
SIMPLEX TRADING, LLC | 02/11/2025 | 65,210 | $899,000 | 100.00% | 0.20% |
CITADEL ADVISORS LLC | 02/14/2025 | 63,800 | $880,440 | -58.00% | 0.19% |
JANE STREET GROUP, LLC | 02/14/2025 | 59,900 | $826,620 | -9.52% | 0.18% |
MARSHALL WACE, LLP | 02/13/2025 | 59,303 | $818,381 | 100.00% | 0.18% |
02/14/2025 | 58,700 | $810,060 | 100.00% | 0.18% | |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 56,120 | $774,456 | 130.88% | 0.17% |
SUPERSTRING CAPITAL MANAGEMENT LP | 02/14/2025 | 55,229 | $762,160 | -83.63% | 0.17% |
Capricor Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 116 institutional investors and hedge funds held shares of Capricor Therapeutics, Inc.. The most heavily invested institutionals were:
GAMMA Investing LLC: 0
BlackRock, Inc.: 2.97 M
VANGUARD GROUP INC: 2.28 M
FARALLON CAPITAL MANAGEMENT LLC: 2.25 M
STATE STREET CORP: 2.21 M
GEODE CAPITAL MANAGEMENT, LLC: 879,468
52.35% of Capricor Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 18.96 M shares in the last 24 months. This purchase volume represents approximately $176.12 M in transactions.